Summary
- Joint and muscle pain are part of the adverse effect profile of gliptins.
- In France, Prescrire carried out a study, using data from the mandatory national health insurance system, showing that patients taking gliptins are more frequently exposed to nonsteroidal anti-inflammatory drugs (NSAIDs) than patients taking other hypoglycaemic drugs for type 2 diabetes.
- These patients are therefore more often exposed to the adverse effects of NSAIDs, without any demonstrated advantage with respect to their diabetes.
Full text available for free download.
©Prescrire 1 November 2019
"Gliptins: joint pain and exposure to NSAIDs" Prescrire Int 2019; 28 (209): 268. (Pdf, free).
| Share |
 |
 |